Oxolife raises €5 million in a funding round and joins the Barcelona Science Park Blog Post

The biotech Oxolife –focused on the development of a new treatment to improve the female fertility rate– has moved its headquarters to the Barcelona Science Park. The company, which has just raised a €5 million funding round, will start a phase II clinical trial to evaluate the efficacy of OXO-001, a drug that specifically acts on embryo implantation to increase pregnancy success rate in assisted reproductive technology processes.

 

EIT Health selects Droplite, Ninevah and Oxolife for Headstart program Blog Post

Droplite, Ninevah Therapeutics and Oxolife, presents at the Barcelona Science Park, are three of the 16 Spanish startups that will participate in Headstart, the program of the European Institute of Innovation and Technology in Health (EIT Health) that offers support and financing of up to 50,000 € because emerging companies develop their innovations within a unique ecosystem, which gives them access to financing, experts, contacts and knowledge.

 

Hallmark Barcelona Science Park innovation Blog Post

2021 was a key year for companies in the life sciences sector, as is clear in the results published in the Biocat Report. A considerable number of these companies are…